Skip to main content
. Author manuscript; available in PMC: 2019 Aug 29.
Published in final edited form as: Vaccine. 2016 May 7;34(27):3030–3036. doi: 10.1016/j.vaccine.2016.04.097

Table 1.

Potentially achievable vs. reported vaccination coverage and 95% confidence interval for 4+DTaP*, 4+PCV, and the Full Series Hib§, by selected socio-demographic factors, National Immunization Survey, United States, 2013.

Factors 4+DTaP 4+PCV Full Series Hib
Potentially achievable
%(95%CI)
Reported
%(95%CI)
Potentially achievable
%(95%CI)
Reported
%(95%CI)
Potentially achievable
%(95%CI)
Reported
%(95%CI)
US National 90.1 ± 1.1** 83.1 ± 1.3 91.3 ± 1.0** 82.0 ± 1.3 92.2 ± 0.9** 82.0 ± 1.3
Health insurance of child No 86.8 ± 2.2 77.0 ± 3.0 86.9 ± 2.3 74.8 ± 2.8 89.1 ± 2.1 75.9 ± 3.0
Yes 90.9 ± 1.2** 84.5 ± 1.4 92.3 ± 1.1** 83.7 ± 1.5 92.9 ± 1.1** 83.5 ± 1.5
Family poverty level Below 87.4 ± 2.3 77.8 ± 2.7 87.5 ± 2.3 74.5 ± 2.7 89.0 ± 2.2 75.8 ± 2.8
At/above 91.6 ± 1.1** 86.0 ± 1.3 93.1 ± 0.9** 86.1 ± 1.4 93.8 ± 0.9** 85.3 ± 1.4
First born child No 88.5 ± 1.5 80.2 ± 1.8 90.2 ± 1.4** 79.3 ± 1.8 91.0 ± 1.3** 79.0 ± 1.8
Yes 92.7 ± 1.4** 87.5 ± 1.7 92.9 ± 1.3** 86.1 ± 1.8 94.0 ± 1.2** 86.6 ± 1.7
Number of children in family 1 92.4 ± 1.8** 86.6 ± 2.1 92.7 ± 1.7** 85.7 ± 2.2 93.7 ± 1.6** 86.2 ± 2.2
≥2 89.3 ± 1.3 81.7 ± 1.6 90.7 ± 1.2** 80.5 ± 1.6 91.6 ± 1.2** 80.3 ± 1.6
Family locality Urban 91.8 ± 3.5** 84.2 ± 4.2 92.5 ± 2.9** 84.8 ± 4.1 95.2 ± 2.2** 85.7 ± 3.7
Suburban 93.1 ± 2.9** 83.8 ± 4.2 92.0 ± 3.3** 84.2 ± 3.9 93.2 ± 2.9** 82.9 ± 4.3
Rural 92.8 ± 3.3** 85.9 ± 4.4 90.1 ± 4.0** 77.7 ± 5.6 92.2 ± 3.7** 79.3 ± 5.5
Family mobility Moved 86.2 ± 3.5 75.5 ± 4.7 85.2 ± 3.6 71.7 ± 4.4 87.1 ± 3.1 72.3 ± 4.8
Not moved 90.6 ± 1.1** 83.9 ± 1.3 91.9 ± 1.0** 83.1 ± 1.4 92.8 ± 1.0** 83.1 ± 1.4
Education level of mother ≤12 years 87.6 ± 2.0 79.3 ± 2.3 88.8 ± 1.9 76.5 ± 2.4 90.4 ± 1.7** 77.8 ± 2.4
≥13 years 92.2 ± 1.1** 86.1 ± 1.3 93.2 ± 1.0** 86.4 ± 1.4 93.6 ± 1.0** 85.4 ± 1.4
Marital status of mother Married 91.7 ± 1.1** 85.5 ± 1.4 92.7 ± 1.0** 84.5 ± 1.5 93.9 ± 0.9** 84.0 ± 1.5
Not married 87.6 ± 2.1 79.0 ± 2.5 88.9 ± 2.0 77.9 ± 2.5 89.4 ± 2.0 78.7 ± 2.5
Age group of mother ≤29 years 87.0 ± 1.9 78.1 ± 2.3 89.1 ± 1.7 77.8 ± 2.3 90.1 ± 1.7** 77.8 ± 2.3
≥30 years 92.7 ± 1.2** 87.1 ± 1.4 93.0 ± 1.1** 85.4 ± 1.6 93.9 ± 1.1** 85.5 ± 1.5
Number of vaccination providers 1 91.0 ± 1.3** 84.0 ± 1.5 92.3 ± 1.2** 83.5 ± 1.6 93.3 ± 1.1** 83.3 ± 1.6
≥2 88.5 ± 1.9 81.4 ± 2.3 89.3 ± 1.9 79.2 ± 2.4 90.2 ± 1.8** 79.5 ± 2.3
Type of vaccination providers Public 90.2 ± 2.4** 80.1 ± 3.8 87.4 ± 3.0 74.6 ± 4.0 89.9 ± 2.5 76.1 ± 4.4
Other 88.7 ± 1.9 82.4 ± 2.1 89.8 ± 1.7 81.3 ± 2.2 90.1 ± 1.8** 80.9 ± 2.2
Private 92.0 ± 1.5** 85.2 ± 1.7 94.1 ± 1.3** 85.1 ± 1.8 95.0 ± 1.2** 85.0 ± 1.7
*

≥ 4 doses of diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine.

4 doses of pneumococcal conjugate vaccine (PCV).

§

Full series Haemophilus influenzae type b (Hib) vaccine: ≥3 or ≥4 doses of Haemophilus influenzae type b (Hib-FS) vaccine depending on product type received (includes primary series plus the booster dose).

95% Confidence Interval.

**

Potentially achievable vaccination coverage would have reached the 90% target.